2.86
Galecto Inc stock is traded at $2.86, with a volume of 32,504.
It is down -11.46% in the last 24 hours and down -28.68% over the past month.
See More
Previous Close:
$3.23
Open:
$3.03
24h Volume:
32,504
Relative Volume:
0.14
Market Cap:
$3.78M
Revenue:
-
Net Income/Loss:
$-38.35M
P/E Ratio:
-1.9724
EPS:
-1.45
Net Cash Flow:
$-36.91M
1W Performance:
-16.62%
1M Performance:
-28.68%
6M Performance:
-75.84%
1Y Performance:
-84.38%
Galecto Inc Stock (GLTO) Company Profile
Name
Galecto Inc
Sector
Industry
Phone
45-70-70-52-10
Address
75 STATE STREET, BOSTON
Compare GLTO with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
GLTO
Galecto Inc
|
2.86 | 3.78M | 0 | -38.35M | -36.91M | -1.45 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.01 | 124.29B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
610.64 | 68.39B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
590.06 | 35.99B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
262.16 | 33.93B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
264.32 | 28.47B | 3.81B | -644.79M | -669.77M | -6.24 |
Galecto Inc Stock (GLTO) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-26-21 | Resumed | Credit Suisse | Outperform |
Nov-23-20 | Initiated | BofA Securities | Buy |
Nov-23-20 | Initiated | Credit Suisse | Outperform |
Nov-23-20 | Initiated | SVB Leerink | Outperform |
Galecto Inc Stock (GLTO) Latest News
Galecto stock hits 52-week low at $3.75 amid market challenges - Investing.com
Galecto stock hits 52-week low at $3.75 amid market challenges By Investing.com - Investing.com South Africa
Galecto stock hits 52-week low at $4.39 amid market challenges - MSN
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Galecto (GLTO) Shares Rally Amid Positive Market Momentum - Stocks Telegraph
Galecto Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Galecto Reports Full-Year 2024 Financial Results - The Manila Times
Galecto Cuts Losses by $17M, Acquires Promising AML Drug Candidate - StockTitan
Galecto Inc expected to post a loss of $2.97 a shareEarnings Preview - TradingView
Idiopathic Pulmonary Fibrosis Clinical Trials 2025: EMA, PDMA, FDA Approvals, Medication, IND, NDA Approvals, Therapies, Mechanism of Action, Route of Administration & Companies by DelveInsight - The Globe and Mail
Galecto stock plunges to 52-week low at $3.76 amid market challenges - Investing.com Australia
Galecto (GLTO) Projected to Post Quarterly Earnings on Friday - Defense World
Mustang Bio Stock Price, Quotes and Forecasts | NASDAQ:MBIO - Benzinga
Ensysce Biosciences Stock Price, Quotes and Forecasts | NASDAQ:ENSC - Benzinga
Galecto stock hits 52-week low at $4.20 amid market challenges - Investing.com Australia
Galecto stock hits 52-week low at $4.20 amid market challenges By Investing.com - Investing.com South Africa
Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World
Reviewing Eton Pharmaceuticals (NASDAQ:ETON) & Galecto (NASDAQ:GLTO) - Defense World
Galecto to Participate in Upcoming Investor Conferences - The Globe and Mail
Galecto stock hits 52-week low at $4.39 amid market challenges By Investing.com - Investing.com South Africa
Leerink Partnrs Estimates Galecto FY2024 Earnings - Defense World
Brokers Set Expectations for Galecto FY2029 Earnings - Armenian Reporter
Galecto to Participate in Upcoming Investor Conferences -February 06, 2025 at 08:01 am EST - Marketscreener.com
Biotech Spotlight: Galecto Lines Up Triple Conference Showcase for Investors - StockTitan
Where are the Opportunities in (GLTO) - Stock Traders Daily
Sunshine Biopharma (NASDAQ:SBFM) Stock Quotes, Forecast and News Summary - Benzinga
Critical Analysis: Galecto (NASDAQ:GLTO) vs. ObsEva (NASDAQ:OBSV) - Defense World
(GLTO) On The My Stocks Page - Stock Traders Daily
Analyzing Galecto (NASDAQ:GLTO) and Pasithea Therapeutics (NASDAQ:KTTA) - Defense World
After layoffs, a viral immunotherapy biotech bounced back with a late-stage prostate cancer win - PharmaVoice
Galecto CEO Hans T. Schambye sells $7,509 in shares - Investing.com
Galecto (NASDAQ:GLTO) Shares Up 22.6% – Should You Buy? - Defense World
When (GLTO) Moves Investors should Listen - Stock Traders Daily
Galecto stock plunges to 52-week low at $4.78 amid market challenges - Investing.com Australia
Galecto stock hits 52-week low at $5.26 amid market challenges - Investing.com Nigeria
Galecto stock hits 52-week low at $5.26 amid market challenges By Investing.com - Investing.com South Africa
Galecto Inc Stock (GLTO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):